MRI Safe Implantable Defibrillator Devices Market
MRI Safe Implantable Defibrillator Devices Market By Product (Single Chamber Defibrillators, Dual Chamber Defibrillators), By Modality (MR Conditional Defibrillators, MR Safe Defibrillators), By End Use (Hospitals, Ambulatory Surgical Centers), & By Region - Global Forecast 2022 to 2032
Analysis of MRI Safe Implantable Defibrillator Devices market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
FREE CustomizationMRI Safe Implantable Defibrillator Devices Market Outlook (2022 to 2032)
The global MRI safe implantable defibrillator devices market is set to enjoy a valuation of US$ 890 million in 2022 and further expand at a CAGR of 6.7% to reach US$ 1.7 billion by 2032-end.
Due to changing lifestyle preferences, high incidence of degenerative & chronic diseases, increase in the number of elderly people, and technological advancements in implantable devices such as high-field MRI, superconducting magnets, software applications, and open architecture, the global market for MRI-safe implantable devices is expanding rapidly across geographies.
| Report Attributes | Details |
|---|---|
| MRI Safe Implantable Defibrillator Devices Market Size (2022E) | US$ 890 Million |
| Forecasted Market Value (2032F) | US$ 1.7 Billion |
| Global Market Growth Rate (2022 to 2032) | 6.7% CAGR |
| North America Market Share (2022) | 24.1% |
| Europe Market Share (2022) | 22.3% |
| Market Share of Top 3 Countries | 35% |
| Key Companies Profiled | Medtronic plc; Zimmer Holdings Inc.; Abbott Laboratories; Cochlear Ltd.; Biotronik; Boston Scientific Corporation; St. Jude Medical Inc; Smiths Medical; AbbVie, Inc.; TriVascular2, Inc.; Stryker Corporation; Smith & Nephew Plc; Johnson & Johnson |
MRI Safe Implantable Defibrillator Device Sales Analysis (2017 to 2021) Vs. Market Forecasts (2022 to 2032)
Devices that are implanted inside the body of the patient and enable the patient to undergo MRI diagnosis safely are known as MRI safe defibrillators. Better images of soft tissues, such as the spine, are produced by the imaging technique known as magnetic resonance induction.
Different types of electromagnetic fields are used during MRI imaging procedures and are predicted to interfere with the leads of cardiac pacemakers or defibrillators. As a result, numerous research projects and clinical studies have been carried out to create better and more sophisticated machines that will enable the patient to have an MRI operation safely.
Demand for MRI safe implantable defibrillator gadgets is growing as a result of factors such as rising ageing population, increase in cardiac disorders, and technological advancements in products.
Expanding at a CAGR of 6.7%, the global MRI-safe implantable defibrillator devices market is projected to reach a size of US$ 1.7 billion by 2032.
What’s Uplifting MRI Safe Implantable Defibrillator Devices Market Growth?
“Technological Advancements, Rising Incidents of Cardiac Diseases, & Growing Number of Senior Population”
A growing elderly population, an increase in cardiac disorders, rising number of eligible people, and several product innovations are some of the factors boosting the market for MRI safe implantable defibrillator systems.
Furthermore, the market for MRI safe implantable defibrillator gadgets is expanding due to the high need for system safety as well as successful marketing initiatives by several manufacturers. The market for MRI-safe defibrillators is also expanding due to additional market variables such as increase in the number of hospitals and rising disposable income, among others.
What is Curbing Sales Growth of MRI Safe Implantable Defibrillator Devices?
“Lack of Skilled Workforce & High Device Cost Hampering Market Expansion”
Besides the market for MRI safe defibrillators' driving forces, certain challenges could impede its expansion.
The market for MRI safe defibrillators may face growing issues such as a shortage of experienced expert professionals and inadequate reimbursement policies. One significant aspect that is anticipated to impede market expansion of MRI safe defibrillators is the high cost of these devices.
What Will Help New Companies Increase their Market Share?
“New Entrants Focusing on Product Innovation, Marketing, & Branding”
There are incredibly few businesses that are engaged in the production of MRI-compatible gadgets. These products were just recently introduced into the market.
- In April 2014, Medtronic announced that the first implantable defibrillator devices that were MRI-safe had received the CE Mark and were available in Europe.
- USFDA recently approved the first Medtronic ICD that is MRI-compatible. A majority of the population still uses implantable defibrillators that are not MRI-compatible despite the introduction of MRI-safe devices.
Companies moving in this route are spending money on research and development projects to advance various device types and produce low-cost MRI safe implanted defibrillator systems.
Due to their dominance, product approvals, market positioning, and lack of competitors, the top 3 players in this market hold a majority of the global market share for MRI safe implantable defibrillator devices.
What Makes North America a Profitable Market for MRI Safe Implantable Defibrillator Producers?
“Advanced Healthcare Infrastructure, High Awareness Regarding Product, & Rising Rate of Implants”
Geographically, North America dominates the market for MRI safe implantable defibrillator solutions because of the region's sophisticated medical facilities, high rate of implants, and favourable reimbursement environment. In 2022, North America is expected to account for 24.1% of the global market share.
Western European nations adhere to this because the CE approves these devices more quickly than the USFDA. Growth is encouraged by the region's high rate of implanted defibrillator use. Due to the lower acceptance rate of these gadgets, Eastern Europe does not represent a sizable market share.
Europe is predicted to hold 22.3% of the global market share, in 2022.
Due to the rise in cardiac disorders, rise in healthcare spending, and rise in medical tourism, APEJ represents a considerable growth opportunity for MRI Safe implantable defibrillator systems over the projection period.
Due to its large senior population and government funding for healthcare institutions, Japan will also have a sizable market share during the forecast period.
Latin America, followed by the Middle East and Africa, has the lowest market share and growth rate for MRI safe implantable defibrillator gadgets over the forecast period, but because of the large number of eligible people living there, these regions offer a sizable market opportunity for competitors.
Will Hospitals Continue Accounting for High Sales of MRI Safe Implantable Defibrillator Devices?
“High Demand from Hospitals Due to Advanced Infrastructure, Presence of Experienced Workforce, & Availability of Reimbursements”
The global MRI safe defibrillator devices market has been divided into hospitals and ambulatory surgical centers, based on end user. It is anticipated that hospitals will account for a sizable portion of market revenue during the forecast period.
Hospitals, clinics, ambulatory surgical centers, and cardiac centers perform the majority of implanted cardioverter defibrillator (ICD) operations. Intensive care units (ICUs), critical care units (CCUs), and emergency rooms are the usual locations for defibrillators.
The most prevalent defibrillators utilized in these facilities are implantable cardioverter defibrillators (ICDs) and automated external defibrillators (AEDs). AEDs are increasingly being employed in hospital settings, even though manual defibrillators are still favoured and frequently used there.
AEDs are increasingly preferred in these facilities due to early defibrillation, faster reaction times, simplicity, cost-effectiveness, and a lack of qualified staff.
The availability of reimbursements in developed markets and the rising frequency of cardiac implant surgeries are the other two key factors positively influencing the hospital segment's growth.
Competitive Landscape
At the moment, the development of implantable defibrillators that are safe for MRIs is being greatly aided by smart innovation. Market players focussing on innovation and improvements are Getinge and Boston Corporation.
Market participants will put more effort into creating novel devices to attract attention across the world. Since 2021, the most frequently used strategies have continued to include technological improvements, new product launches, research and development, acquisitions, expansions, and collaborations.
- DirectSense Technology, a novel instrument for observing the impact of radiofrequency energy delivery during cardiac ablation procedures, was recently released by Boston Corporation.
Key Segments in MRI Safe Implantable Defibrillator Devices Industry Research
-
By Product :
- Single Chamber Defibrillators
- Dual Chamber Defibrillators
-
By Modality :
- MR Conditional Defibrillators
- MR Safe Defibrillators
-
By End Use :
- Hospitals
- Ambulatory Surgical Centers
-
By Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- MEA
Table of Content
- 1. Global Market - Executive Summary
- 2. Global Market Overview
- 3. Market Risks and Trends Assessment
- 4. Market Background and Foundation Data Points
- 5. Global Market Demand (US$ Mn) Analysis 2017 to 2021 and Forecast, 2022 to 2032
- 6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Modality
- 6.1. MR Conditional Defibrillators
- 6.2. MR Safe Defibrillators
- 7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, by Product
- 7.1. Single Chamber Defibrillators
- 7.2. Dual Chamber Defibrillators
- 8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, by End Use
- 8.1. Hospitals
- 8.2. Ambulatory Surgical Centers
- 9. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, by Region
- 9.1. North America
- 9.2. Latin America
- 9.3. Europe
- 9.4. East Asia
- 9.5. South Asia & Oceania
- 9.6. Middle East and Africa (MEA)
- 10. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032
- 11. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032
- 12. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032
- 13. East Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032
- 14. South Asia & Oceania Market Analysis 2017 to 2021 and Forecast 2022 to 2032
- 15. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2032
- 16. Market Structure Analysis
- 17. Competition Analysis
- 17.1. Medtronic plc
- 17.2. Zimmer Holdings Inc.
- 17.3. Abbott Laboratories
- 17.4. Cochlear Ltd.
- 17.5. Biotronik
- 17.6. Boston Scientific Corporation
- 17.7. St. Jude Medical Inc.
- 17.8. Smiths Medical
- 17.9. AbbVie, Inc.
- 17.10. TriVascular2, Inc.
- 17.11. Stryker Corporation
- 17.12. Smith & Nephew Plc
- 17.13. Johnson & Johnson
- 18. Assumptions And Acronyms Used
- 19. Research Methodology
List Of Table
Table 01: Global Market Value (US$ Mn) Analysis, by Modality, 2017 to 2021
Table 02: Global Market Value (US$ Mn) Analysis, by Modality, 2022 to 2032
Table 03: Global Market Value (US$ Mn) Opportunity Analysis, by Modality, 2022 to 2032
Table 04: Global Market Value (US$ Mn) Analysis, by Product, 2017 to 2021
Table 05: Global Market Value (US$ Mn) Analysis, by Product, 2022 to 2032
Table 06: Global Market Value (US$ Mn) Opportunity Analysis, by Product, 2022 to 2032
Table 07: Global Market Value (US$ Mn) Analysis, by End Use, 2017 to 2021
Table 08: Global Market Value (US$ Mn) Analysis, by End Use, 2022 to 2032
Table 09: Global Market Value (US$ Mn) Opportunity Analysis, by End Use, 2022 to 2032
Table 10: Global Market Value (US$ Mn) Analysis, by Region, 2017 to 2021
Table 11: Global Market Value (US$ Mn) Analysis, by Region, 2022 to 2032
Table 12: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2022 to 2032
Table 13: North America Market Value (US$ Mn) Analysis, by Country, 2017 to 2021
Table 14: North America Market Value (US$ Mn) Analysis, by Country, 2022 to 2032
Table 15: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2032
Table 16: North America Market Value (US$ Mn) Analysis, by Modality, 2017 to 2021
Table 17: North America Market Value (US$ Mn) Analysis, by Modality, 2022 to 2032
Table 18: North America Market Value (US$ Mn) Opportunity Analysis, by Modality, 2022 to 2032
Table 19: North America Market Value (US$ Mn) Analysis, by Product, 2017 to 2021
Table 20: North America Market Value (US$ Mn) Analysis, by Product, 2022 to 2032
Table 21: North America Market Value (US$ Mn) Opportunity Analysis, by Product, 2022 to 2032
Table 22: North America Market Value (US$ Mn) Analysis, by End Use, 2017 to 2021
Table 23: North America Market Value (US$ Mn) Analysis, by End Use, 2022 to 2032
Table 24: North America Market Value (US$ Mn) Opportunity Analysis, by End Use, 2022 to 2032
Table 25: Latin America Market Value (US$ Mn) Analysis, by Country, 2017 to 2021
Table 26: Latin America Market Value (US$ Mn) Analysis, by Country, 2022 to 2032
Table 27: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2032
Table 28: Latin America Market Value (US$ Mn) Analysis, by Modality, 2017 to 2021
Table 29: Latin America Market Value (US$ Mn) Analysis, by Modality, 2022 to 2032
Table 30: Latin America Market Value (US$ Mn) Opportunity Analysis, by Modality, 2022 to 2032
Table 31: Latin America Market Value (US$ Mn) Analysis, by Product, 2017 to 2021
Table 32: Latin America Market Value (US$ Mn) Analysis, by Product, 2022 to 2032
Table 33: Latin America Market Value (US$ Mn) Opportunity Analysis, by Product, 2022 to 2032
Table 34: Latin America Market Value (US$ Mn) Analysis, by End Use, 2017 to 2021
Table 35: Latin America Market Value (US$ Mn) Analysis, by End Use, 2022 to 2032
Table 36: Latin America Market Value (US$ Mn) Opportunity Analysis, by End Use, 2022 to 2032
Table 37: Europe Market Value (US$ Mn) Analysis, by Country, 2017 to 2021
Table 38: Europe Market Value (US$ Mn) Analysis, by Country, 2022 to 2032
Table 39: Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2032
Table 40: Europe Market Value (US$ Mn) Analysis, by Modality, 2017 to 2021
Table 41: Europe Market Value (US$ Mn) Analysis, by Modality, 2022 to 2032
Table 42: Europe Market Value (US$ Mn) Opportunity Analysis, by Modality, 2022 to 2032
Table 43: Europe Market Value (US$ Mn) Analysis, by Product, 2017 to 2021
Table 44: Europe Market Value (US$ Mn) Analysis, by Product, 2022 to 2032
Table 45: Europe Market Value (US$ Mn) Opportunity Analysis, by Product, 2022 to 2032
Table 46: Europe Market Value (US$ Mn) Analysis, by End Use, 2017 to 2021
Table 47: Europe Market Value (US$ Mn) Analysis, by End Use, 2022 to 2032
Table 48: Europe Market Value (US$ Mn) Opportunity Analysis, by End Use, 2022 to 2032
Table 49: East Asia Market Value (US$ Mn) Analysis, by Country, 2017 to 2021
Table 50: East Asia Market Value (US$ Mn) Analysis, by Country, 2022 to 2032
Table 51: East Asia Market Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2032
Table 52: East Asia Market Value (US$ Mn) Analysis, by Modality, 2017 to 2021
Table 53: East Asia Market Value (US$ Mn) Analysis, by Modality, 2022 to 2032
Table 54: East Asia Market Value (US$ Mn) Opportunity Analysis, by Modality, 2022 to 2032
Table 55: East Asia Market Value (US$ Mn) Analysis, by Product, 2017 to 2021
Table 56: East Asia Market Value (US$ Mn) Analysis, by Product, 2022 to 2032
Table 57: East Asia Market Value (US$ Mn) Opportunity Analysis, by Product, 2022 to 2032
Table 58: East Asia Market Value (US$ Mn) Analysis, by End Use, 2017 to 2021
Table 59: East Asia Market Value (US$ Mn) Analysis, by End Use, 2022 to 2032
Table 60: East Asia Market Value (US$ Mn) Opportunity Analysis, by End Use, 2022 to 2032
Table 61: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2017 to 2021
Table 62: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2022 to 2032
Table 63: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2032
Table 64: South Asia & Oceania Market Value (US$ Mn) Analysis, by Modality, 2017 to 2021
Table 65: South Asia & Oceania Market Value (US$ Mn) Analysis, by Modality, 2022 to 2032
Table 66: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Modality, 2022 to 2032
Table 67: South Asia & Oceania Market Value (US$ Mn) Analysis, by Product, 2017 to 2021
Table 68: South Asia & Oceania Market Value (US$ Mn) Analysis, by Product, 2022 to 2032
Table 69: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Product, 2022 to 2032
Table 70: South Asia & Oceania Market Value (US$ Mn) Analysis, by End Use, 2017 to 2021
Table 71: South Asia & Oceania Market Value (US$ Mn) Analysis, by End Use, 2022 to 2032
Table 72: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by End Use, 2022 to 2032
Table 73: MEA Market Value (US$ Mn) Analysis, by Country, 2017 to 2021
Table 74: MEA Market Value (US$ Mn) Analysis, by Country, 2022 to 2032
Table 75: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2032
Table 76: MEA Market Value (US$ Mn) Analysis, by Modality, 2017 to 2021
Table 77: MEA Market Value (US$ Mn) Analysis, by Modality, 2022 to 2032
Table 78: MEA Market Value (US$ Mn) Opportunity Analysis, by Modality, 2022 to 2032
Table 79: MEA Market Value (US$ Mn) Analysis, by Product, 2017 to 2021
Table 80: MEA Market Value (US$ Mn) Analysis, by Product, 2022 to 2032
Table 81: MEA Market Value (US$ Mn) Opportunity Analysis, by Product, 2022 to 2032
Table 82: MEA Market Value (US$ Mn) Analysis, by End Use, 2017 to 2021
Table 83: MEA Market Value (US$ Mn) Analysis, by End Use, 2022 to 2032
Table 84: MEA Market Value (US$ Mn) Opportunity Analysis, by End Use, 2022 to 2032
List Of Figures
Figure 01: Global Market Value (US$ Mn) Historical Analysis, 2017 to 2021
Figure 02: Global Market Value (US$ Mn) Forecast and Analysis, 2022 to 2032
Figure 03: Global Market Value Y-o-Y Growth and Forecast, 2017 to 2032
Figure 04: Global Market Incremental $ Opportunity, 2022 to 2032
Figure 05: Global Market Share and BPS Analysis by Modality, 2022 & 2032
Figure 06: Global Market Y-o-Y Growth Projections by Modality, 2022 to 2032
Figure 07: Global Market Attractiveness Analysis by Modality, 2022 to 2032
Figure 08: Global Market Share and BPS Analysis by Product, 2022 & 2032
Figure 09: Global Market Y-o-Y Growth Projections by Product, 2022 to 2032
Figure 10: Global Market Attractiveness Analysis by Product, 2022 to 2032
Figure 11: Global Market Share and BPS Analysis by End Use, 2022 & 2032
Figure 12: Global Market Y-o-Y Growth Projections by End Use, 2022 to 2032
Figure 13: Global Market Attractiveness Analysis by End Use, 2022 to 2032
Figure 14: Global Market Share and BPS Analysis by Region, 2022 & 2032
Figure 15: Global Market Y-o-Y Growth Projections by Region, 2022 to 2032
Figure 16: Global Market Attractiveness Analysis by Region, 2022 to 2032
Figure 17: North America Market Value (US$ Mn) Historical Analysis, 2017 to 2021
Figure 18: North America Market Value (US$ Mn) Forecast and Analysis, 2022 to 2032
Figure 19: North America Market Value Y-o-Y Growth and Forecast, 2032
Figure 20: North America Market Incremental $ Opportunity, 2022 to 2032
Figure 21: North America Market Share Analysis by Country, 2022 & 2032
Figure 22: North America Market Y-o-Y Growth Projection by Country, 2022 to 2032
Figure 23: North America Market Attractiveness Analysis by Country, 2022 to 2032
Figure 24: North America Market Share and BPS Analysis by Modality, 2022 & 2032
Figure 25: North America Market Y-o-Y Growth Projections by Modality, 2022 to 2032
Figure 26: North America Market Attractiveness Analysis by Modality, 2022 to 2032
Figure 27: North America Market Share and BPS Analysis by Product, 2022 & 2032
Figure 28: North America Market Y-o-Y Growth Projections by Product, 2022 to 2032
Figure 29: North America Market Attractiveness Analysis by Product, 2022 to 2032
Figure 30: North America Market Share and BPS Analysis by End Use, 2022 & 2032
Figure 31: North America Market Y-o-Y Growth Projections by End Use, 2022 to 2032
Figure 32: North America Market Attractiveness Analysis by End Use, 2022 to 2032
Figure 33: Latin America Market Value (US$ Mn) Historical Analysis, 2017 to 2021
Figure 34: Latin America Market Value (US$ Mn) Forecast and Analysis, 2022 to 2032
Figure 35: Latin America Market Value Y-o-Y Growth and Forecast, 2017 to 2032
Figure 36: Latin America Market Incremental $ Opportunity, 2022 to 2032
Figure 37: Latin America Market Share Analysis by Country, 2022 & 2032
Figure 38: Latin America Market Y-o-Y Growth Projection by Country, 2022 to 2032
Figure 39: Latin America Market Attractiveness Analysis by Country, 2022 to 2032
Figure 40: Latin America Market Share and BPS Analysis by Modality, 2022 & 2032
Figure 41: Latin America Market Y-o-Y Growth Projections by Modality, 2022 to 2032
Figure 42: Latin America Market Attractiveness Analysis by Modality, 2022 to 2032
Figure 43: Latin America Market Share and BPS Analysis by Product, 2022 & 2032
Figure 44: Latin America Market Y-o-Y Growth Projections by Product, 2022 to 2032
Figure 45: Latin America Market Attractiveness Analysis by Product, 2022 to 2032
Figure 46: Latin America Market Share and BPS Analysis by End Use, 2022 & 2032
Figure 47: Latin America Market Y-o-Y Growth Projections by End Use, 2022 to 2032
Figure 48: Latin America Market Attractiveness Analysis by End Use, 2022 to 2032
Figure 49: Europe Market Value (US$ Mn) Historical Analysis, 2017 to 2021
Figure 50: Europe Market Value (US$ Mn) Forecast and Analysis, 2022 to 2032
Figure 51: Europe Market Value Y-o-Y Growth and Forecast, 2017 to 2032
Figure 52: Europe Market Incremental $ Opportunity, 2022 to 2032
Figure 53: Europe Market Share Analysis by Country, 2022 & 2032
Figure 54: Europe Market Y-o-Y Growth Projection by Country, 2022 to 2032
Figure 55: Europe Market Attractiveness Analysis by Country, 2022 to 2032
Figure 56: Europe Market Share and BPS Analysis by Modality, 2022 & 2032
Figure 57: Europe Market Y-o-Y Growth Projections by Modality, 2022 to 2032
Figure 58: Europe Market Attractiveness Analysis by Modality, 2022 to 2032
Figure 59: Europe Market Share and BPS Analysis by Product, 2022 & 2032
Figure 60: Europe Market Y-o-Y Growth Projections by Product, 2022 to 2032
Figure 61: Europe Market Attractiveness Analysis by Product, 2022 to 2032
Figure 62: Europe Market Share and BPS Analysis by End Use, 2022 & 2032
Figure 63: Europe Market Y-o-Y Growth Projections by End Use, 2022 to 2032
Figure 64: Europe Market Attractiveness Analysis by End Use, 2022 to 2032
Figure 65: East Asia Market Value (US$ Mn) Historical Analysis, 2017 to 2021
Figure 66: East Asia Market Value (US$ Mn) Forecast and Analysis, 2022 to 2032
Figure 67: East Asia Market Value Y-o-Y Growth and Forecast, 2017 to 2032
Figure 68: East Asia Market Incremental $ Opportunity, 2022 to 2032
Figure 69: East Asia Market Share Analysis by Country, 2022 & 2032
Figure 70: East Asia Market Y-o-Y Growth Projection by Country, 2022 to 2032
Figure 71: East Asia Market Attractiveness Analysis by Country, 2022 to 2032
Figure 72: East Asia Market Share and BPS Analysis by Modality, 2022 & 2032
Figure 73: East Asia Market Y-o-Y Growth Projections by Modality, 2022 to 2032
Figure 74: East Asia Market Attractiveness Analysis by Modality, 2022 to 2032
Figure 75: East Asia Market Share and BPS Analysis by Product, 2022 & 2032
Figure 76: East Asia Market Y-o-Y Growth Projections by Product, 2022 to 2032
Figure 77: East Asia Market Attractiveness Analysis by Product, 2022 to 2032
Figure 78: East Asia Market Share and BPS Analysis by End Use, 2022 & 2032
Figure 79: East Asia Market Y-o-Y Growth Projections by End Use, 2022 to 2032
Figure 80: East Asia Market Attractiveness Analysis by End Use, 2022 to 2032
Figure 81: South Asia & Oceania Market Value (US$ Mn) Historical Analysis, 2017 to 2021
Figure 82: South Asia & Oceania Market Value (US$ Mn) Forecast and Analysis, 2022 to 2032
Figure 83: South Asia & Oceania Market Value Y-o-Y Growth and Forecast, 2017 to 2032
Figure 84: South Asia & Oceania Market Incremental $ Opportunity, 2022 to 2032
Figure 85: South Asia & Oceania Market Share Analysis by Country, 2022 & 2032
Figure 86: South Asia & Oceania Market Y-o-Y Growth Projection by Country, 2022 to 2032
Figure 87: South Asia & Oceania Market Attractiveness Analysis by Country, 2022 to 2032
Figure 88: South Asia & Oceania Market Share and BPS Analysis by Modality, 2022 & 2032
Figure 89: South Asia & Oceania Market Y-o-Y Growth Projections by Modality, 2022 to 2032
Figure 90: South Asia & Oceania Market Attractiveness Analysis by Modality, 2022 to 2032
Figure 91: South Asia & Oceania Market Share and BPS Analysis by Product, 2022 & 2032
Figure 92: South Asia & Oceania Market Y-o-Y Growth Projections by Product, 2022 to 2032
Figure 93: South Asia & Oceania Market Attractiveness Analysis by Product, 2022 to 2032
Figure 94: South Asia & Oceania Market Share and BPS Analysis by End Use, 2022 & 2032
Figure 95: South Asia & Oceania Market Y-o-Y Growth Projections by End Use, 2022 to 2032
Figure 96: South Asia & Oceania Market Attractiveness Analysis by End Use, 2022 to 2032
Figure 97: MEA Market Value (US$ Mn) Historical Analysis, 2017 to 2021
Figure 98: MEA Market Value (US$ Mn) Forecast and Analysis, 2022 to 2032
Figure 99: MEA Market Value Y-o-Y Growth and Forecast, 2017 to 2032
Figure 100: MEA Market Incremental $ Opportunity, 2022 to 2032
Figure 101: MEA Market Share Analysis by Country, 2022 & 2032
Figure 102: MEA Market Y-o-Y Growth Projection by Country, 2022 to 2032
Figure 103: MEA Market Attractiveness Analysis by Country, 2022 to 2032
Figure 104: MEA Market Share and BPS Analysis by Modality, 2022 & 2032
Figure 105: MEA Market Y-o-Y Growth Projections by Modality, 2022 to 2032
Figure 106: MEA Market Attractiveness Analysis by Modality, 2022 to 2032
Figure 107: MEA Market Share and BPS Analysis by Product, 2022 & 2032
Figure 108: MEA Market Y-o-Y Growth Projections by Product, 2022 to 2032
Figure 109: MEA Market Attractiveness Analysis by Product, 2022 to 2032
Figure 110: MEA Market Share and BPS Analysis by End Use, 2022 & 2032
Figure 111: MEA Market Y-o-Y Growth Projections by End Use, 2022 to 2032
Figure 112: MEA Market Attractiveness Analysis by End Use, 2022 to 2032
- FAQs -
What is the valuation of the MRI safe implantable defibrillator devices market?
The global MRI safe implantable defibrillator devices market is valued at US$ 890 million.
What is the predicted growth rate for the market?
Sales of MRI safe implantable defibrillator devices are set to increase at 6.7% CAGR.
Which regional market is lucrative for MRI-safe implantable defibrillator device producers?
North America leads with around one-fourth market share.
What is the market share of the top 3 countries?
Top 3 countries manufacturing MRI-safe implantable defibrillator devices account for 35% share.
MRI Safe Implantable Defibrillator Devices Market